Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Curajel™ Oral Gel

K-Number: K260126 · 2026-06-15

Decision Date2026-06-15
Product CodeOLR
DecisionSubstantially Equivalent

Device Summary

Curajel™ Oral Gel is the device name listed in this FDA 510(k) record. The listed applicant is USpharma, Ltd.. It received FDA 510(k) clearance on 2026-06-15 under 510(k) number K260126. The device is classified under product code OLR. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Curajel™ Oral Gel?

Curajel™ Oral Gel is a medical device that received FDA 510(k) clearance on 2026-06-15. The listed applicant is USpharma, Ltd.. The 510(k) number is K260126.

When did Curajel™ Oral Gel receive FDA 510(k) clearance?

Curajel™ Oral Gel received FDA 510(k) clearance on 2026-06-15, under 510(k) number K260126.

Who is the listed applicant for Curajel™ Oral Gel?

The FDA 510(k) record lists USpharma, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Curajel™ Oral Gel?

The FDA product code for Curajel™ Oral Gel is OLR.

Related Devices (Code: OLR)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.